Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Screening people for blood and heart research studies

Checks whether people with blood conditions or healthy volunteers can join other research studies.

Plain-language title generated from the registry record
Registry title: Screening for Hematology Branch Protocols

Key facts

Where
Bethesda, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 2 and 100 years old?

Source: NCT00001620, who can take part

Where in United States

  • National Institutes of Health Clinical CenterBethesda, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
National Heart, Lung, and Blood Institute (NHLBI)
Trial code
NCT00001620
Record updated
9 November 2026
Original description
This study allows the evaluation of subjects in order to determine their ability to safely participate in other active research studies.Read full original descriptionShow less

Screening Protocol for Subjects Being Evaluated for National Heart, Lung and Blood Institute (NHLBI) Protocols

This study allows the evaluation of subjects in order to determine their ability to safely participate in other active research studies.

After subjects complete the screening process, they will be offered the opportunity to participate in an active research study, or if no appropriate studies are available information and recommendations will be provided for other treatment options....

Exclusion: All subjects not fulfilling the inclusion criteria will be considered ineligible.

INCLUSION CRITERIA:; Subjects will be entered on this protocol at the time of their first visit to the NIH Clinical Center outpatient clinic or inpatient service if:; The subject carries the diagnosis of a disorder for which the NHLBI has an active research protocol, and based on information received from an outside physician, he/she appears to meet at least preliminary eligibility criteria for that protocol; OR; The subject is a donor for a subject for whom the NHLBI has an active stem cell transplant protocol and based on information received from an outside physician, he/she appears to meet preliminary eligibility as a donor; OR; The subject is a normal volunteer for whom the NHLBI has an active study recruiting healthy normal volunteers and he/she appears to meet preliminary eligibility as a normal volunteer; Age >= 2 and Weight >12 kg (healthy volunteers age >=8); The subject, the subject's guardian (if the subject is a minor), or the subject's legally authorized representative (LAR) is capable of informed consent, and willing to sign the consent form after initial counseling by clinical staff. Separate consent forms for all interventional or surgical procedures will be obtained after explanation of the specific procedure.

ClinicalTrials.gov NCT00001620